| 1 | [SID87225451] | Active | IC50 | 14.4 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Active | | IC50 | 14.4 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 2 | [SID87225451] | Active | IC50 | 14.4 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Active | | IC50 | 14.4 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 3 | [SID87225451] | Active | IC50 | 15.5 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Active | | IC50 | 15.5 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 4 | [SID87225451] | Active | IC50 | 15.5 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Active | | IC50 | 15.5 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 5 | [SID87225451] | Active | IC50 | 17.3 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Active | | IC50 | 17.3 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 6 | [SID87225451] | Active | IC50 | 17.3 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Active | | IC50 | 17.3 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 7 | [SID49640730] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 8 | [SID49640730] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 9 | [SID49640730] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 10 | [SID49640730] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 11 | [SID49640730] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 12 | [SID49640730] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 13 | [SID49640730] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 14 | [SID49640730] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 15 | [SID49640730] | Active | | | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) [AID434939, Type: screening] | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) | | AID | 434939 | | BioAssay type | screening | | Target | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] | | PubMed | | | Data Table |  |
|
| 16 | [SID49640730] | Active | | | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) [AID434939, Type: screening] | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Aryl Hydrocarbon Receptor (AHR): luminescence-based cell-based high throughput screening assay to identify activators of the Pregnane X Receptor (PXR) | | AID | 434939 | | BioAssay type | screening | | Target | nuclear receptor subfamily 1 group I member 2 isoform 1 [Homo sapiens] [gi:34398348] | | PubMed | | | Data Table |  |
|
| 17 | [SID49640730] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 18 | [SID49640730] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 19 | [SID49640730] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2233 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 20 | [SID49640730] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2233 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 21 | [SID49640730] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 22 | [SID49640730] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 23 | [SID49640730] | Active | | | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme [AID493105_4, Type: other] | lysophospholipase 2 [Mus musculus] [gi:123122209] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme | | AID | 493105 | | BioAssay type | other | | Target | lysophospholipase 2 [Mus musculus] [gi:123122209] | | PubMed | | | Data Table |  |
|
| 24 | [SID49640730] | Active | | | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme [AID493105_4, Type: other] | lysophospholipase 2 [Mus musculus] [gi:123122209] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme | | AID | 493105 | | BioAssay type | other | | Target | lysophospholipase 2 [Mus musculus] [gi:123122209] | | PubMed | | | Data Table |  |
|
| 25 | [SID49640730] | Active | | | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme [AID493105_2, Type: other] | Lysophospholipase II [gi:74755840] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme | | AID | 493105 | | BioAssay type | other | | Target | Lysophospholipase II [gi:74755840] | | PubMed | | | Data Table |  |
|
| 26 | [SID49640730] | Active | | | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme [AID493105_2, Type: other] | Lysophospholipase II [gi:74755840] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition of recombinant and endogenous enzyme | | AID | 493105 | | BioAssay type | other | | Target | Lysophospholipase II [gi:74755840] | | PubMed | | | Data Table |  |
|
| 27 | [SID49640730] | Active | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 28 | [SID49640730] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 29 | [SID49640730] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 30 | [SID49640730] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 31 | [SID49640730] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 32 | [SID49640730] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 33 | [SID49640730] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 34 | [SID49640730] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49640730] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats [AID652065, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats | | AID | 652065 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID49640730] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 37 | [SID49640730] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2232, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2232 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 38 | [SID49640730] | Active | | | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex [AID652068, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex | | AID | 652068 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID49640730] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] | LYPLA2 gene product [Homo sapiens] [gi:9966764] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity | | AID | 652030 | | BioAssay type | other | | Target | LYPLA2 gene product [Homo sapiens] [gi:9966764] | | PubMed | | | Data Table |  |
|
| 40 | [SID49640730] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 41 | [SID49640730] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_3, Type: other] | Lypla1 [Mus musculus] [gi:71059731] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity | | AID | 652030 | | BioAssay type | other | | Target | Lypla1 [Mus musculus] [gi:71059731] | | PubMed | | | Data Table |  |
|
| 42 | [SID49640730] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_2, Type: other] | lysophospholipase 2 [Mus musculus] [gi:123122209] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity | | AID | 652030 | | BioAssay type | other | | Target | lysophospholipase 2 [Mus musculus] [gi:123122209] | | PubMed | | | Data Table |  |
|
| 43 | [SID49640730] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 44 | [SID49640730] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 45 | [SID49640730] | Inactive | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Inactive | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID49640730] | Inactive | Potency | 16.4816 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Inactive | | Potency | 16.4816 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID49640730] | Inactive | Potency | 19.9526 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 48 | [SID87225451] | Inactive | IC50 | 20 | SAR analysis of compounds that are cytotoxic to HEK293 revised [AID2335, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 87225451 | | CID | 1130125 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that are cytotoxic to HEK293 revised | | AID | 2335 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID49640730] | Inactive | Potency | 35.4813 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 50 | [SID49640730] | Inactive | Potency | 89.1251 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49640730 | | CID | 1130125 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|